[1]
E. Akdaş, “Stressful life events, psychiatric comorbidities and serum neuromediator levels in patients with chronic spontaneous urticaria treated with omalizumab”, Allergol Immunopathol, vol. 52, no. 3, pp. 1–7, May 2024, doi: 10.15586/aei.v52i3.1015.